Po-chun Hsieh
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Biopsy-Proven Pulmonary Tumors Detected by LDCT: A 10-Year Single-Center Study of Growth Patterns and Diagnostic Pitfalls.
Journal: International journal of medical sciences
Published: August 12, 2025
Sodium-potassium-chloride cotransporter 1 as a novel regulator of DAMPs-mediated alveolar epithelial-macrophage crosstalk in LPS-induced lung inflammation.
Journal: Biochemical pharmacology
Published: August 05, 2025
Significant determinants of plasma procalcitonin concentrations in adult patients hospitalized in intensive care units with monomicrobial Gram-negative bacteremia.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: June 09, 2025
Therapeutic effects of Jing Si herbal tea for chronic obstructive pulmonary disease: a comprehensive investigation from clinical to basic research.
Journal: Frontiers in pharmacology
Published: May 20, 2025
Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
Journal: The Journal of antimicrobial chemotherapy
Published: May 02, 2025
Comparisons of acupuncture therapies combining conventional treatment in the management of vascular cognitive impairment: a systematic review and network meta-analysis.
Journal: Frontiers in aging neuroscience
Published: January 12, 2025
Comparative Analysis of ICS Combined with LABA versus Addition of Omalizumab on Transcriptomic Expression Profiles in Patients with Allergic Asthma.
Journal: Journal of asthma and allergy
Published: December 17, 2024
Distributions of plasmidic genes encoding extended-spectrum and AmpC β-lactamases, and susceptibilities of global non-carbapenemase-producing meropenem-resistant Enterobacterales to ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam-avibactam, 2017-2022.
Journal: The Journal of infection
Published: December 13, 2024
Geographic variations in distributions of carbapenemase-encoding genes, susceptibilities, and minimum inhibitory concentrations of inpatient meropenem-resistant Enterobacterales to ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam-avibactam across four global regions: 2020-2022 data from the Antimicrobial Testing Leadership and Surveillance.
Journal: International journal of antimicrobial agents
Published: November 14, 2024
Comparison of CogMate™ and the Mini-Mental State Examination: A New Tool for Assessing the Cognitive Function of Community-Dwelling Older People.
Journal: Dementia and geriatric cognitive disorders
Published: November 07, 2024
Anti-inflammatory and polarization-modulating effects of Houttuynia cordata in LPS-stimulated RAW264.7 macrophages.
Journal: Journal of traditional and complementary medicine
Published: October 28, 2024
Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?
Journal: Expert review of anti-infective therapy
Published: October 09, 2024
Last Updated: 09/26/2026